Browse the full insider trade history of Corline Biomedical AB, a listed issuer based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, Corline Biomedical AB has published 1 insider filings. Market capitalisation: €467.8m. The latest transaction was filed on 17 February 2026 (Purchase). Among the most active insiders: Henrik Nittmar. All data is accessible without an account.